- Initial charge
- $297
- Supply description
- Three-month plan
- Renewal
- $297 every 11 weeks
- Monthly headline
- $99 equivalent; not a monthly payment
A NAD+ program within a wider service
Brello Health offers a standalone compounded NAD+ plan alongside combination longevity programs and other treatments. This profile concentrates on the standalone NAD+ purchase so its price is not confused with a bundle containing a GLP-1 or sermorelin. Each component of a combined program still depends on a provider's assessment and prescription when appropriate.
The public process describes paying for a plan, completing a health intake and undergoing clinical review before medication is supplied. We have not enrolled or tested the service. A payment is therefore not evidence that a patient will receive a prescription, and advertised shipping timelines begin at a different stage from an initial purchase.
The actual charge is more useful than the headline
The NAD+ page advertises a $99 monthly equivalent but states that $297 is charged for the three-month plan. Both the product page and checkout terms say the plan renews at $297 every eleven weeks. That renewal cycle is shorter than three calendar months and needs to appear beside the price in a continuing budget.
Dividing $297 by three explains the $99 headline, but it does not create a month-by-month payment option. Nor does it show that a twelve-month commitment consists of exactly four payments. Use the actual invoice dates for cash-flow planning, especially when another provider bills on a calendar-month basis.
Cancellation and refunds use different deadlines
The checkout terms state that future renewals should be stopped at least two business days before the next billing date. They also distinguish that action from refunding an existing order. A general cancel-anytime statement should therefore be read as the ability to stop future activity under the applicable conditions, not as an unrestricted return policy.
For certain first-order cancellations after the provider review, the checkout terms describe a twelve-hour request window and a $50 professional fee. The product page contains different timing language. Confirm which terms govern the selected order before relying on the longer window, and retain the checkout agreement rather than resolving the discrepancy by assumption.
What to establish about the preparation
Brello identifies the product as compounded and not FDA-approved. Its pages describe supplies and provider support, but the exact vial concentration, quantity and pharmacy instructions must be confirmed for the patient-specific order. A stated three-month plan does not independently establish the storage life of every container supplied within it.
Discuss the intended purpose and evidence for the actual preparation with the clinician, keeping marketed energy or wellness benefits separate from demonstrated outcomes. Brello adds a well-documented upfront charge and renewal cadence to the register. Its unresolved details concern the final prescription, complete inclusions and conflicting refund-window wording, which should be clarified before an order moves into fulfillment.
Useful distinctions
- Full upfront charge published
- Eleven-week renewal stated explicitly
- Checkout terms distinguish renewals from existing orders
Limitations to weigh
- Refund timing differs across public pages
- Vial specifications require confirmation
- No independent assessment of outcomes or service quality
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.